Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Clinical genetics · KIDINS220-related disorder

Understanding Your Child's Diagnosis: KIDINS220-Related Disorders

At a Glance

KIDINS220-related disorders are an ultra-rare spectrum caused by changes in the KIDINS220 gene. SINO and VENARG describe overlapping patterns, while symptoms and outlook vary; genetic counseling and coordinated neurologic, eye, and physical care help families plan next steps.

The journey to a diagnosis is often long and exhausting, and receiving a name for your child’s condition can bring a complicated mix of relief and overwhelming uncertainty [1]. Your child has been diagnosed with a KIDINS220-related disorder, a term that describes a spectrum of conditions caused by changes in the KIDINS220 gene. Historically, this condition was often called SINO syndrome, but as doctors have learned more, they now use the broader umbrella of KIDINS220-related disorders to better describe the variety of symptoms and genetic patterns seen in different children [2][3].

An Exceptionally Rare Discovery

You are now part of a very small global community. This condition is ultra-rare, with fewer than 50 published individuals in the reviewed literature as of mid-2025 [4][5]. Because there are so few cases, your local doctors may have never encountered this diagnosis before. This rarity means that while your local team will provide daily care, you may need to work with specialized neurogenetics centers to access the most current understanding of the disorder [6][7].

Understanding the Labels: SINO vs. VENARG

When you look at your child’s genetic report, you might see several different names. These are not separate diseases, but overlapping descriptions on the same spectrum. Not every child fits neatly into either label. The names usually depend on which specific “glitch” occurred in the gene and how it was inherited [2].

  • SINO Syndrome: This is an acronym for the four main features originally identified: Spastic paraplegia (stiff muscles), Intellectual disability (learning challenges), Nystagmus (involuntary eye movements), and Obesity [8][9]. It is usually autosomal dominant, meaning only one copy of the gene has a mutation. Often, this mutation is de novo, meaning it happened for the first time in the child and was not passed down by the parents [8][10].
  • VENARG: This label describes a distinct presentation associated with severe Ventriculomegaly (enlarged fluid spaces in the brain), Neonatal Arthrogryposis (joint contractures), and sometimes Retinal or renal abnormalities [2]. This version is typically autosomal recessive, meaning the child inherited a mutated copy of the gene from both parents [2][11].
  • Macrocephaly: Many children also have macrocephaly, which is the medical term for a larger-than-average head size [9]. This is often related to how the brain’s fluid-filled spaces, called ventricles, develop [5].

What Science Knows (and What is Uncertain)

The KIDINS220 gene provides instructions for a protein that is essential for the survival and growth of nerve cells. When the gene is altered, it disrupts how signals travel through the brain and to the muscles [5][8].

While we understand the “why” behind the genetics, the “how” of the future is often less clear. Because so few children have been diagnosed, there is no single “roadmap” for how the condition progresses [4]. Some children may have mild motor delays, while others face more significant physical and cognitive challenges [3][2]. It is common for structural brain features to become clearer as a child grows and their brain matures, which is why follow-up imaging (like an MRI) is often considered when clinically indicated [9].

Navigating the Emotional Impact

Receiving a diagnosis for an ultra-rare condition is a significant life event. It is normal to feel a range of emotions, including:

  • Grief and Fear: Many parents describe grieving the “expected” future and feeling deep anxiety about what lies ahead [12][13].
  • Isolation: Because the condition is so rare, you may feel like no one understands your experience. This “social disconnection” is a common challenge for rare-disease families [12][14].
  • Empowerment: Over time, many parents find that having a name for the condition allows them to focus their care, connect with peer support groups, and become powerful advocates for their child [15][16].

Your Next Steps

While the diagnosis is rare, you do not have to manage it alone. Experts recommend the following steps to build a foundation for your child’s care:

  1. Genetic Counseling: Meet with a genetic counselor to review your child’s specific variant. They can explain the inheritance pattern and what it means for siblings or future family planning [17][18].
  2. Multidisciplinary Care: Because this condition affects the brain, eyes, and muscles, your child will likely need a team that includes a pediatric neurologist, ophthalmologist (eye doctor), and physical therapist [6][19].
  3. The “Medical Home”: Identify one specialist—often a pediatrician or neurologist—who can act as the “hub” for your child’s care, helping to coordinate between different doctors [20][21].
  4. Connect with Peers: Look for online communities for rare genetic disorders and KIDINS220 specifically. These groups can provide practical tips that aren’t yet in medical textbooks [16][22].

Common questions in this guide

What is a KIDINS220-related disorder?
A KIDINS220-related disorder is an ultra-rare genetic condition caused by a change in the KIDINS220 gene, which helps nerve cells survive and grow. Children can have different combinations and levels of movement, learning, eye, head-size, and brain-development differences.
How are SINO and VENARG different?
They are overlapping labels for patterns within the KIDINS220-related disorder spectrum, not necessarily separate diseases. SINO commonly includes stiff muscles, intellectual or learning challenges, involuntary eye movements, and obesity, while VENARG is associated with enlarged brain fluid spaces and joint contractures in newborns. A child may not fit neatly into either label.
Did my child inherit the KIDINS220 change from us?
It depends on the specific genetic change. SINO is usually linked to one altered copy and often starts as a new change in the child, while VENARG is typically linked to two altered copies, one from each parent. A genetic counselor can explain what the result means for siblings and future family planning.
What does macrocephaly mean in a KIDINS220-related disorder?
Macrocephaly means that a child's head is larger than average. In KIDINS220-related disorders, it may relate to how the brain's fluid-filled spaces, called ventricles, develop. Doctors may consider a follow-up MRI when it is clinically appropriate.
Which specialists should be on my child's care team?
Care may include a pediatric neurologist, pediatric neurogenetics specialist, ophthalmologist, physical therapist, and genetic counselor. A pediatrician or neurologist can serve as the central coordinator, helping the different specialists work together.
What is the outlook for children with KIDINS220-related disorders?
Because fewer than 50 individuals were described in the reviewed literature by mid-2025, doctors cannot predict one typical course. Some children have mild motor delays, while others have more significant physical and learning challenges, and brain features may become clearer as the child grows. Ongoing follow-up helps the care team adjust support to the child's needs.

Get notified when new evidence is published on Macrocephaly-spastic paraplegia-dysmorphism syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (22)
  1. 1

    After genomic testing results: Parents' long-term views.

    Liang NSY, Adam S, Elliott AM, et al.

    Journal of genetic counseling 2022; (31(1)):82-95 doi:10.1002/jgc4.1454.

    PMID: 34165210
  2. 2

    Novel autosomal recessive SINO syndrome-associated KIDINS220 variants provide insight into the genotype-phenotype correlation.

    Yang W, Wang S, Huo X, et al.

    Heliyon 2024; (10(17)):e37355 doi:10.1016/j.heliyon.2024.e37355.

    PMID: 39296002
  3. 3

    Detection of pathogenic novel intronic splicing variants in the KIDINS220 gene causes motor developmental delay.

    Bai L, Hei Y, Tian R, et al.

    Artificial cells, nanomedicine, and biotechnology 2026; (54(1)):74-84 doi:10.1080/21691401.2026.2612914.

    PMID: 41521563
  4. 4

    A novel KIDINS220 mutation associated with hereditary spastic paraplegia accompanied by severe peripheral neuropathy.

    Chu X, Xu J, Zheng Y, et al.

    Frontiers in neuroscience 2025; (19()):1684980 doi:10.3389/fnins.2025.1684980.

    PMID: 41164410
  5. 5

    Refining the phenotype of SINO syndrome: A comprehensive cohort report of 14 novel cases.

    Alstrup M, Cesca F, Krawczun-Rygmaczewska A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(11)):101219 doi:10.1016/j.gim.2024.101219.

    PMID: 39033379
  6. 6

    Consensus clinical management guidelines for Alström syndrome.

    Tahani N, Maffei P, Dollfus H, et al.

    Orphanet journal of rare diseases 2020; (15(1)):253 doi:10.1186/s13023-020-01468-8.

    PMID: 32958032
  7. 7

    Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.

    Pignolo RJ, Bedford-Gay C, Cali A, et al.

    Orphanet journal of rare diseases 2022; (17(1)):168 doi:10.1186/s13023-022-02224-w.

    PMID: 35436894
  8. 8

    Heterozygous KIDINS220/ARMS nonsense variants cause spastic paraplegia, intellectual disability, nystagmus, and obesity.

    Josifova DJ, Monroe GR, Tessadori F, et al.

    Human molecular genetics 2016; (25(11)):2158-2167 doi:10.1093/hmg/ddw082.

    PMID: 27005418
  9. 9

    A Novel KIDINS220 Pathogenic Variant Associated with the Syndromic Spastic Paraplegia SINO: An Expansion of the Brain Malformation Spectrum and a Literature Review.

    Bonati MT, Baldoli C, Taurino J, et al.

    Genes 2024; (15(9)) doi:10.3390/genes15091190.

    PMID: 39336781
  10. 10

    SINO Syndrome Causative KIDINS220/ARMS Gene Regulates Adipocyte Differentiation.

    Zhang K, Sun W, Liu Y, et al.

    Frontiers in cell and developmental biology 2021; (9()):619475 doi:10.3389/fcell.2021.619475.

    PMID: 33763417
  11. 11

    Homozygous KIDINS220 loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures.

    Mero IL, Mørk HH, Sheng Y, et al.

    Human molecular genetics 2017; (26(19)):3792-3796 doi:10.1093/hmg/ddx263.

    PMID: 28934391
  12. 12

    Using Interpretative Phenomenological Analysis to Explore the Experiences of Mothers Who Have a Child With the Rare Genetic Disorder, HNRNPU-Related Neurodevelopmental Disorder: "Some Days, I Wear a Cape and I'm Super Mom and Some Days, I Have to Hide Under My Cape and I Can't Get Out for a Few Days".

    Overton I, Docherty F, Balasubramanian M

    Journal of genetic counseling 2026; (35(5)).

    PMID: 42922377
  13. 13

    Beyond illness severity: transdiagnostic cognitive vulnerabilities as independent predictors of psychological distress in parents of children with rare genetic disorders.

    Cuturilo G, Vukosavljevic Gvozden T, Gvozden M, et al.

    Frontiers in psychiatry 2026; (17()):1963031 doi:10.3389/fpsyt.2026.1963031.

    PMID: 42871252
  14. 14

    The supportive care needs of parents with a child with a rare disease: results of an online survey.

    Pelentsov LJ, Fielder AL, Laws TA, Esterman AJ

    BMC family practice 2016; (17()):88 doi:10.1186/s12875-016-0488-x.

    PMID: 27439905
  15. 15

    Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders.

    Rosell AM, Pena LD, Schoch K, et al.

    Journal of genetic counseling 2016; (25(5)):1019-31 doi:10.1007/s10897-016-9933-1.

    PMID: 26868367
  16. 16

    Social Media Use Among Parents and Caregivers of Children With Rare Genetic Diseases: Scoping Review.

    Davis C, Bogaert L, Powell J, Low K

    Journal of medical Internet research 2025; (27()):e77087 doi:10.2196/77087.

    PMID: 41313807
  17. 17

    Exploring the experience of communication in healthcare settings with parents of children with a rare genetic condition: "It's the more negative ones that you remember".

    Burbury L, Ayres S, Boyle J, et al.

    Journal of genetic counseling 2025; (34(4)):e70102 doi:10.1002/jgc4.70102.

    PMID: 40831303
  18. 18

    Survey of patient satisfaction with genetic counseling services in Korea.

    Choi IH, Kim YK, Yang SY, et al.

    Journal of genetic counseling 2025; (34(1)):e1922 doi:10.1002/jgc4.1922.

    PMID: 38769825
  19. 19

    Health care, social, educational, and employment needs of individuals affected by rare diseases and their families in Catalonia, Spain.

    Calmaestra-Carrillo E, Vernet R, Torrent-Farnell J, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 41764575
  20. 20

    Alone in a Crowd? Parents of Children with Rare Diseases' Experiences of Navigating the Healthcare System.

    Baumbusch J, Mayer S, Sloan-Yip I

    Journal of genetic counseling 2018; doi:10.1007/s10897-018-0294-9.

    PMID: 30128673
  21. 21

    Patient experiences of interprofessional collaboration and intersectoral communication in rare disease healthcare in Germany - a mixed-methods study.

    Inhestern L, Otto R, Brandt M, et al.

    Orphanet journal of rare diseases 2024; (19(1)):197 doi:10.1186/s13023-024-03207-9.

    PMID: 38741100
  22. 22

    Attitudes about the use of internet support groups and the impact among parents of children with Cornelia de Lange syndrome.

    Cacioppo CN, Conway LJ, Mehta D, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2016; (172(2)):229-36 doi:10.1002/ajmg.c.31504.

    PMID: 27163126

This page is for informational purposes only and does not constitute medical advice about your child's KIDINS220-related disorder. A genetic counselor and your child's medical team should interpret the genetic result and guide follow-up and care.